| Log In | Register Now
Sunday, May 27, 2012 4:54 AM EDT
Alzheimer's disease (AD), also called Alzheimer disease, senile dementia of the Alzheimer type (SDAT), primary degenerative dementia of the Alzheimer's type(PDDAT), or simply Alzheimer's, is the most common form of dementia. This incurable, degenerative, and terminal disease was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him. Most often, it is diagnosed in people over 65 years of age, although the less-prevalent early-onset Alzheimer'scan occur much earlier. In 2006, there were 26.6 million sufferers worldwide. Alzheimer's is predicted to affect 1 in 85 people globally by 2050. Read More
By Quality stocks
Today, Adeona Pharmaceuticals, Inc., a developer of innovative medicines used in the treatment of serious central nervous system diseases, announced that it has executed an agreement with TG United, Inc. of Brooksville, FL, to provide commercial-scale manufacturing capabilities for reaZin. (Apr 21, 2011)
MORE TOPICS: MANUFACTURING, COPPER, MANAGEMENT
By Quality stocks
Odds are that most people know someone suffering from Alzheimer’s disease, the debilitating form of dementia which affects memory, thinking, and behavior, given that there are more than 5.3 million Americans suffering today from it. (Mar 15, 2011)
MORE TOPICS: GERMANY, NEW JERSEY, CANCER
By Quality stocks
Intellect Neurosciences, Inc., a biotechnology company with several drugs in various stages of development, released more data today regarding it lead Alzheimer’s candidate, OX1 (Oxigon™), which has recently completed a Phase 1b clinical trial. (Dec 27, 2010)
MORE TOPICS: AGING
By Quality stocks
Anavex Life Sciences Corp. today announced that it has filed the regulatory submission for its lead compound for the treatment of Alzheimer’s disease, ANAVEX 2-73, with the German Health Authority, BfArM, and the local Ethics Committee of Saxony. (Dec 22, 2010)
MORE TOPICS: CANCER
By Quality stocks
Neuralstem, Inc., developer of patented technology with the ability to produce neural stem cells of the human brain and spinal cord, today announced that the U.S. Food and Drug Administration (FDA) has given its approval for an Investigational New Dr... (Dec 16, 2010)
By IBTimes
Heavy smoking during the middle age doubles the risk of Alzheimer's disease and dementia later in life, a study published on Monday reveals. (Oct 27, 2010)
MORE TOPICS: CALIFORNIA
